Galactosylhydroxylysine
Galactosylhydroxylysine is a component of bone collagen produced by post-translational glycosylation of hydroxylysine. Galactosylhydroxylysine is released during bone resorption and has been shown to be elevated in metabolic bone loss[1].
Product Specifications
CAS Number
[32448-36-5]
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Galactosylhydroxylysine.html
Solubility
10 mM in DMSO
Smiles
N[C@@H](CCC(O[C@H]1[C@@H]([C@H]([C@H]([C@@H](CO)O1)O)O)O)CN)C(O)=O
Molecular Formula
C12H24N2O8
Molecular Weight
324.33
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Leigh SD, et al. Development of an immunoassay for urinary galactosylhydroxylysine. J Immunol Methods. 1998;220 (1-2) :169-178.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Pseudopleuronectes americanus Solute carrier family 22 member 6 (SLC22A6), partial
Recombinant Pseudopleuronectes americanus Solute carrier family 22 member 6 (SLC22A6), partial
Herpes Simplex Virus I, Strain HFEM (HSV I) (MaxLight 750) discontinued